Article Details

Phase 2 Trial Expanded to Examine AGEN1181 Plus Balstilimab in Colon Cancer

Retrieved on: 2020-12-03 21:11:15

Tags for this article:

Click the tags to see associated articles and topics

Phase 2 Trial Expanded to Examine AGEN1181 Plus Balstilimab in Colon Cancer. View article details on hiswai:

Excerpt

... anti–PD-1 human <b>monoclonal antibody</b> balstilimab (AGEN2034) in patients with colon cancer, according to an announcement from Agenus Inc.<sup>1</sup>.

Article found on: www.onclive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo